Table 2.
Lipid Class % |
Group 1 Normal TAG, wt PNPLA3 |
Group 2 Normal TAG, var PNPLA3 |
Group 3 High TAG, wt PNPLA3 |
Group 4 High TAG, var PNPLA3 |
---|---|---|---|---|
TAG | 25.63 ± 12.49 | 35.22 ± 15.30 | 68.64 ± 11.26 *** | 69.82 ± 11.86 *** |
DAG | 0.60 ± 0.30 | 0.57 ± 0.17 | 0.92 ± 0.12 * | 1.02 ± 0.20 ** |
FFA | 7.23 ± 3.57 | 6.07 ± 1.71 | 2.60 ± 1.12 *** | 2.37 ± 1.01 ** |
CER | 0.26 ± 0.04 | 0.25 ± 0.08 | 0.10 ± 0.03 *** | 0.10 ± 0.05 *** |
DCER | 0.03 ± 0.01 | 0.03 ± 0.01 | 0.01 ± 0.00 *** | 0.01 ± 0.01 *** |
HCER | 0.07 ± 0.02 | 0.05 ± 0.02 | 0.03 ± 0.01 *** | 0.02 ± 0.01 ** |
LCER | 0.06 ± 0.01 | 0.06 ± 0.03 | 0.04 ± 0.02 | 0.03 ± 0.01 |
PC | 38.51 ± 9.74 | 33.06 ± 8.63 | 14.86 ± 6.41 *** | 14.75 ± 7.83 *** |
LPC | 0.66 ± 0.22 | 0.60 ± 0.14 | 0.24 ± 0.14 *** | 0.28 ± 0.17 ** |
PE | 20.43 ± 5.80 | 17.84 ± 5.82 | 8.19 ± 3.24 *** | 7.29 ± 3.10 *** |
LPE | 0.16 ± 0.05 | 0.15 ± 0.03 | 0.06 ± 0.03 *** | 0.07 ± 0.04 *** |
CE | 2.45 ± 0.34 | 2.84 ± 0.45 | 2.73 ± 0.60 | 2.86 ± 0.48 |
SM | 3.91 ± 0.81 | 3.28 ± 0.81 | 1.59 ± 0.67 *** | 1.37 ± 0.60 *** |
TAG: triacylglycerols, DAG: diacylglycerols, FFA: free fatty acids, CER: ceramides, DCER: dihydroceramides, HCER: hexosylceramides, LCER: lactosylceramides, PC: phosphatidylcholines, LPC: lysophosphatidylcholines, PE: phosphatidylethanolamines, LPE: lysophosphatidylethanolamines, CE: cholesterol esters, SM: sphingomyelins; wt: wild-type allele with I148I; var: I148M variants, which encode I148M (heterozygous) or M148M (homozygous) variants, respectively. Numbers denote averages ± standard deviations. * denotes significant differences between group 3 vs. 1 or group 4 vs. 2 illustrating the effect of liver TAG content; * p < 0.05, ** p < 0.01, *** p < 0.001. Significance was calculated using ANOVA with Holm-Sidak´s post-hoc test and assumed as p < 0.05. By the comparisons of group 2 vs. 1 and group 4 vs. 3 no significant differences were found for I148M PNPLA3 variant vs. wild-type carriers.